DFFN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 Aug 2023 @ 16:00):

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease...

Stats
Today's Volume	349 445
Average Volume	47 812.00
Market Cap	8.98M
EPS	$0 ( 2024-05-13 )
Next earnings date	( $0 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.619
ATR14	$0.214 (3.24%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-20	Tanner John William	Buy	32 000	Stock Option (Right to Buy)
2023-11-09	Gregoire Sylvie	Sell	10 000	Common Stock
2023-11-09	Alam John J	Sell	12 500	Common Stock
2023-09-15	Cobuzzi Robert Joseph Jr.	Buy	16 000	Stock Option (Right to Buy)
2023-09-15	Tanner John William	Buy	16 000	Stock Option (Right to Buy)

INSIDER POWER
44.93
Last 93 transactions
Buy: 1 964 449 \| Sell: 147 821

Volume Correlation

Long: 0.13 (neutral)

Short: 0.96 (very strong)

Signal:(78.616) Expect same movement, but be aware

Diffusion Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Diffusion Pharmaceuticals Correlation - Currency/Commodity

-0.61
( weak negative )

-0.57
( weak negative )

0.51
( weak )

-0.70
( moderate negative )

0.36
( neutral )

Diffusion Pharmaceuticals Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-7.46

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-7.46

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-12.50

FY	2020
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-15.00

Financial Reports:

No articles found.

Diffusion Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Diffusion Pharmaceuticals